News

NEW YORK, NY, USA I April 28, 2025 I IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune diseases, ...
Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.
It is a tricky task for startups to raise funding. Editor's note: Make sure to bookmark this page to follow the latest startup accelerator programs deadlines as we keep updating the list. Want to ...